Evidence map›Paper›PMID 32187815›Full record

ArticleChemMedChem2020

N-Substituted Nipecotic Acids as (S)-SNAP-5114 Analogues with Modified Lipophilic Domains.

Michael C Böck, Georg Höfner, Klaus T Wanner

Abstract read
In one paragraph

Article in ChemMedChem, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. KInternational journal of molecular sciences · 2020
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michael C BöckDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstraße 5-13, 81377, Munich, Germany.ORCID 0000-0002-8758-4912
Georg HöfnerDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstraße 5-13, 81377, Munich, Germany.
Klaus T WannerDepartment of Pharmacy - Center for Drug Research, Ludwig-Maximilians-Universität München, Butenandtstraße 5-13, 81377, Munich, Germany.ORCID 0000-0003-4399-1425

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Potential mGAT4 inhibitors derived from the lead substance (S)-SNAP-5114 have been synthesized and characterized for their inhibitory potency. Variations from the parent compound included the substitution of one of its aromatic 4-methoxy and 4-methoxyphenyl groups, respectively, with a more polar moiety, including a carboxylic acid, alcohol, nitrile, carboxamide, sulfonamide, aldehyde or ketone function, or amino acid partial structures. Furthermore, it was investigated how the substitution of more than one of the aromatic 4-methoxy groups affects the potency and selectivity of the resulting compounds. Among the synthesized test substances (S)-1-{2-[(4-formylphenyl)bis(4-methoxyphenyl)-methoxy]ethyl}piperidine-3-carboxylic acid, that features a carbaldehyde function in place of one of the aromatic 4-methoxy moieties of (S)-SNAP-5114, was found to have a pIC

Indexed as

Dose-Response Relationship, DrugEnzyme InhibitorsGABA Uptake InhibitorsHEK293 CellsHumansHydrophobic and Hydrophilic InteractionsMolecular StructureN-AcetylglucosaminyltransferasesNipecotic AcidsStructure-Activity RelationshipEnzyme InhibitorsGABA Uptake InhibitorsMGAT4A protein, humanN-AcetylglucosaminyltransferasesNipecotic AcidsGABA uptake inhibitorsmedicinal chemistrymGAT4neurochemistrystructure-activity relationships

Identifiers

PMID32187815
PMCPMC7317212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.